Still, like other alternative sweeteners, allulose may cause adverse effects in certain people
Binding affinity data from Hruby and colleagues' foundational work at Arizona (published through the 1990s and 2000s in the Journal of Medicinal Chemistry) established that MT2 has substantially greater potency than alpha-MSH across the receptor panel, with a particularly pronounced gain at MC4R relative to MC1R
However, based on the available research, 12mg appears to offer the broadest range of potential benefits while remaining well within established safety limits.11 For that reason, we generally favored products delivering 12mg per serving when developing our recommendations
Animal models suggest some passage, but human data is absent
Brands like Rybelsus, Ozempic, and Wegovy utilize semaglutide differently, adapting it for both diabetes management and weight loss goals
The newer dual-action agent tirzepatide (Mounjaro) targets both GLP-1 and GIP receptors and is licensed in the UK for type 2 diabetes management